-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Merck & Co, Raises Price Target to $145

Benzinga·10/12/2026 20:17:48
Listen to the news
Citigroup analyst Geoff Meacham maintains Merck & Co (NYSE:MRK) with a Neutral and raises the price target from $125 to $145.